홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
SLS
#2542
SELLAS Life Sciences Group, Inc. Common Stock
4.8
6
USD
+2.10%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+2.10%
월간 변동
-10.83%
6달 변화
+127.10%
년간 변동율
+326.32%
이전 종가
4.7
6
Open
4.8
6
Bid
Ask
Low
4.8
6
High
4.8
6
양
50
마켓
주식
헬스케어
SLS
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
15.08 M
15.91 M
28.3 M
56.27 M
90.85 M
179.58 M
—
Valuation ratios
Enterprise value
52.34 M
66.61 M
55.05 M
48.11 M
80.59 M
605.23 M
1.07 B
Price to earnings ratio
—
-4.13
-1.2
-0.67
-2.08
-15.08
-31.57
Price to sales ratio
—
11.26
37.55
47.62
—
—
—
Price to cash flow ratio
—
-3.29
-2.08
-0.8
-1.8
-14.48
-26.46
Price to book ratio
—
4.21
10.2
-3.13
6.72
5.8
10.88
EBITDA 비율에 대한 기업 가치
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.36
-0.79
-1.97
-6
-1.59
-0.34
-0.6
Return on equity %
-0.6
-1.02
-8.51
4.68
-3.26
-0.38
-0.72
Return on invested capital %
-578.16
-1 092.1
-2 687.38
-2 413.58
-3 529.88
-3 087.1
—
Gross margin %
100
97.37
92.41
100
—
—
—
Operating margin %
-881.72
-332.55
-3 185.27
-7 213.14
—
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
-870.04
-272.14
-3 135.99
-7 112.38
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
2.99
4.63
1.14
0.23
1.72
10.72
28.55
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.06
0.21
0.06
0.04
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-1.68
-1.23
-1.13
-0.58
-0.26
-0.29
EBIT per share
—
-1.63
-2.15
-1.34
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
1.38
0.88
0.09
0.23
0.66
1.65
Net current asset value per share
—
1.49
0.92
0.11
0.27
0.69
1.81
Tangible book value per share
—
1.19
0.15
-0.36
0.12
0.63
1.58
Working capital per share
—
1.17
0.12
-0.38
0.11
0.63
1.55
Book value per share
—
1.31
0.25
-0.29
0.15
0.65
1.65
뉴스
SELLAS, 2상 AML 임상시험 첫 환자 등록
SELLAS enrolls first patient in Phase 2 AML trial of SLS009
셀라스 생명과학, 워런트 행사로 4,260만 달러 조달
Sellas Life Sciences reports $42.6 million in warrant exercise proceeds
What's Going With SELLAS Life Sciences Stock On Wednesday? - SELLAS Life Sciences Gr (NASDAQ:SLS)
H.C. Wainwright, Solaris Resources 목표 주가 16달러로 상향
H.C. Wainwright raises Solaris Resources stock price target to $16 on Warintza progress
Why I’m Selling Sellas Life Sciences Ahead Of The REGAL Reveal (NASDAQ:SLS)
Solaris Resources, 52주 신고가 $8.54 기록
SELLAS, 유럽서 SLS009 임상시험 위해 IMPACT-AML과 협력
SELLAS partners with IMPACT-AML for European SLS009 trials
Lam Research, Micron Tech among market cap stock movers on Tuesday